Author Archives: Pete Shuster

CEO and Owner at Neuromics-Biotechnology industry

Bioreagents company specializing in providing reagents and methods for the Neuroscience Research Community. As a natural extension, we are growing our catalog to serve Diabetes/Obesity and Cancer Research.

In addition to antibodies, proteins, primary neurons and stem cell reagents, we have unique products expertise in delivering DsiRNA both in vivo and in vitro.

Intra-i-Fect Tissue Specific siRNA Kits

I have published content here on our collaborator’s success using i-Fect to delivery siRNA in vivo and in-vitro. These kits have been used for gene expression analysis studies of DOR, hTERT, The β3 subunit of the Na+,K+-ATPase, rSNSR1, NTS1. NAV1.8, Survivin,  Flaviviruses and more.
I am excited about another iteration of capablilities with our new:
Intra-i-Fect Tissue Specific [...]

Dr. Steve Hall knows Stem Cells

 
Developing New Methods, Applications and Reagents for Regenerative Medicine and Stem Cell Research.

 Getting Started with Alphagenix                    
Steve is an advisor, collaborator and friend. He has the innate ability to bring his his scientific expertise and entrepreneural insticts together in a way that anticipates emerging needs of the research community we both serve. He is an expert [...]

Dr. Steve Stice to Present the Power of StemEZ Neural Cells

I have profiled Steve Stice’s research here. The focus has been the excellent research results he and his team at ArunA Biomedical have generated with STEMEZ(TM) hN2 Human Neurons and hNP1 Human Neural Progenitors.
The story continues. He will be presenting the latest at the 9th Annual World Pharmaceutical Congress in Philadelphia, June 14. Topics include: using these [...]

Coming Soon-Dr. Steve Hall

Dr Steve Hall has been a friend, collaborator and mentor since I purchased Neuromics. This includes being a Neuromics’ Premier supplier of Stem Cells and Related Markers, Media and Methods. Steve is currently President at AlphaGenix, Inc.
His expertise includes developing novel products and technologies for basic and clinical research with a particular emphasis on stem [...]

Studying Apoptosis In Tumors

I have featured Gary Johnson here.
I value my partnership with his compant, ICT. They provide our customers with potent and research proven Apoptosis Kits and Methods. Here we feature publications referencing our MitoPT™ Kits. These Kits easily assess changes in mitochondrial membrane potential. Changes in mitochondrial membrane potential can correlate with cytochrome c release and the initiation of [...]

TCE and Parkinson’s

This post introduces a new twist to “News Behind the Neuroscience News”. This report was graciously submitted by Ms Pamela Brown of associatesdegree.com. I welcome her initiative in submitting this. On a side note, when I did factory work in the 1970s, trichloroethylene was a universal solvent used to clean parts. Wow. We will add [...]

Opioid-Induced Hyperalgesia and CaMKII alpha

Many of my backstories have featured Pain Researchers.  In several, I have featured use of our our i-Fect ™ Transfection Kit for enhancing the delivery of siRNA in vitro and in vivo to study the expression of genes invovled in Neuropathic and Nociceptive Pain.
I am excited to present a recent publication that includes use of this kit [...]

Hope for Stroke Victims-Transplanting STEMEZ hNP1 Cells

Hope for Stroke Victims-Transplanting STEMEZ hNP1 Cells
Posted using ShareThis

Featuring Dr. Pat Carr

Amyotrophic Lateral Sclerosis (ALS)-New Twists on Root Causes

Teacher, Mentor and Friend    Dr. Pat Carr has been a key figure in helping shape the direction of my company. He has a gift for communicating the nuances of his research and coaching me on how to best serve labs like his. Based on these interactions, it came as no surprise [...]

Spinal Cord Injury Repair

I wanted to feature yet more research on spinal cord injury repair.
Dr. Mark Tuszynski and his team of researchers at USCD recently published work that tested their hypothesis that chemotropic mechanisms would guide regenerating spinal cord axons to appropriate brainstem targets.
Laura Taylor Alto, Leif A Havton, James M Conner, Edmund R Hollis II, Armin Blesch & [...]